IBDEI2HM ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39721,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,39721,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,39722,0)
 ;;=D57.1^^152^2000^187
 ;;^UTILITY(U,$J,358.3,39722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39722,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,39722,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,39722,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,39723,0)
 ;;=D75.1^^152^2000^185
 ;;^UTILITY(U,$J,358.3,39723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39723,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,39723,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,39723,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,39724,0)
 ;;=C90.30^^152^2000^188
 ;;^UTILITY(U,$J,358.3,39724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39724,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,39724,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,39724,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,39725,0)
 ;;=D56.3^^152^2000^189
 ;;^UTILITY(U,$J,358.3,39725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39725,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,39725,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,39725,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,39726,0)
 ;;=D56.9^^152^2000^190
 ;;^UTILITY(U,$J,358.3,39726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39726,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,39726,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,39726,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,39727,0)
 ;;=M31.1^^152^2000^192
 ;;^UTILITY(U,$J,358.3,39727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39727,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,39727,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,39727,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,39728,0)
 ;;=D51.2^^152^2000^193
 ;;^UTILITY(U,$J,358.3,39728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39728,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,39728,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,39728,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,39729,0)
 ;;=D05.92^^152^2000^36
 ;;^UTILITY(U,$J,358.3,39729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39729,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,39729,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,39729,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,39730,0)
 ;;=D05.91^^152^2000^38
 ;;^UTILITY(U,$J,358.3,39730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39730,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,39730,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,39730,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,39731,0)
 ;;=D05.90^^152^2000^34
 ;;^UTILITY(U,$J,358.3,39731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39731,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,39731,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,39731,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,39732,0)
 ;;=D51.0^^152^2000^194
 ;;^UTILITY(U,$J,358.3,39732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39732,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,39732,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,39732,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,39733,0)
 ;;=D51.1^^152^2000^195
 ;;^UTILITY(U,$J,358.3,39733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39733,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
